THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 108 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $670,853 | -16.6% | 77,735 | 0.0% | 0.00% | – |
| Q2 2023 | $804,557 | -4.6% | 77,735 | 0.0% | 0.00% | – |
| Q1 2023 | $843,425 | -3.3% | 77,735 | 0.0% | 0.00% | – |
| Q4 2022 | $872,187 | +10.7% | 77,735 | 0.0% | 0.00% | – |
| Q3 2022 | $788,000 | +11.9% | 77,735 | 0.0% | 0.00% | – |
| Q2 2022 | $704,000 | -5.2% | 77,735 | 0.0% | 0.00% | – |
| Q1 2022 | $743,000 | -13.3% | 77,735 | +0.3% | 0.00% | – |
| Q4 2021 | $857,000 | +63.9% | 77,535 | +9.6% | 0.00% | – |
| Q3 2021 | $523,000 | -49.1% | 70,735 | 0.0% | 0.00% | – |
| Q2 2021 | $1,027,000 | -28.9% | 70,735 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $1,444,000 | +5.9% | 70,735 | -7.8% | 0.00% | 0.0% |
| Q4 2020 | $1,364,000 | +20.2% | 76,735 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,135,000 | -30.7% | 76,735 | -1.7% | 0.00% | 0.0% |
| Q2 2020 | $1,638,000 | +9.9% | 78,035 | +20.9% | 0.00% | 0.0% |
| Q1 2020 | $1,491,000 | -10.3% | 64,535 | +0.5% | 0.00% | 0.0% |
| Q4 2019 | $1,663,000 | +35.6% | 64,235 | +2.1% | 0.00% | 0.0% |
| Q3 2019 | $1,226,000 | +19.3% | 62,935 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,028,000 | -28.0% | 62,935 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,427,000 | -11.4% | 62,935 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,611,000 | -22.5% | 62,935 | -1.1% | 0.00% | 0.0% |
| Q3 2018 | $2,079,000 | +48.3% | 63,635 | +2.9% | 0.00% | 0.0% |
| Q2 2018 | $1,402,000 | -3.0% | 61,835 | +3.7% | 0.00% | 0.0% |
| Q1 2018 | $1,446,000 | -15.3% | 59,635 | -2.6% | 0.00% | 0.0% |
| Q4 2017 | $1,708,000 | -18.6% | 61,235 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $2,097,000 | -14.1% | 61,235 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,440,000 | +18.0% | 61,235 | +9.1% | 0.00% | 0.0% |
| Q1 2017 | $2,067,000 | +13.3% | 56,135 | -1.9% | 0.00% | 0.0% |
| Q4 2016 | $1,825,000 | -12.0% | 57,235 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $2,074,000 | +58.1% | 57,235 | -1.0% | 0.00% | +100.0% |
| Q2 2016 | $1,312,000 | +113.3% | 57,839 | +76.7% | 0.00% | 0.0% |
| Q1 2016 | $615,000 | +23.2% | 32,739 | +7.6% | 0.00% | – |
| Q4 2015 | $499,000 | +49.0% | 30,439 | 0.0% | 0.00% | – |
| Q3 2015 | $335,000 | -91.2% | 30,439 | -89.6% | 0.00% | -100.0% |
| Q2 2015 | $3,812,000 | +21.6% | 292,777 | +62.0% | 0.00% | 0.0% |
| Q1 2015 | $3,135,000 | +111.8% | 180,697 | +82.2% | 0.00% | +200.0% |
| Q4 2014 | $1,480,000 | +13.4% | 99,170 | +75.2% | 0.00% | 0.0% |
| Q3 2014 | $1,305,000 | -27.7% | 56,611 | -0.0% | 0.00% | -50.0% |
| Q2 2014 | $1,805,000 | – | 56,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |